The Economics of the Legal Cannabis Market in 2024

Legal cannabis is expected to generate over $30 billion in United States sales in 2024. While storefronts look sleek and customer demand is incredibly high, the businesses behind the counter are fighting a quiet financial battle. Severe banking restrictions and punishing federal tax codes are squeezing profit margins, leaving many state-legal marijuana dispensaries struggling to survive.

The Cash-Only Crisis

If you walk into a dispensary today, you will likely need to pay with crisp dollar bills or use a cashless ATM that rounds your purchase up to the nearest ten dollars. This is not a choice made by the business owners. It is a forced reality.

Because marijuana remains a Schedule I controlled substance under federal law, major financial institutions like JPMorgan Chase, Bank of America, and Wells Fargo refuse to offer standard business checking accounts or merchant processing to cannabis companies. Providing banking services to a federally illegal enterprise puts these banks at risk of federal money laundering charges.

Operating as a heavily cash-based business creates several massive operational hurdles:

• Security Costs: Dispensaries must hire armed security guards and contract with armored truck services like Brink’s or Loomis to move cash safely.
• Targeting by Criminals: Cash-heavy businesses are prime targets for burglaries. In areas like Oakland and Seattle, dispensaries have faced coordinated armed robberies, threatening both employee safety and business continuity.
• Exorbitant Banking Fees: A small number of state-chartered credit unions do work with cannabis businesses, but they charge steep compliance fees. A standard business might pay zero dollars for a checking account, while a dispensary could pay up to $5,000 a month just to keep an account open.

Lawmakers have introduced the SAFER Banking Act to solve this issue. This legislation would protect financial institutions from federal penalties for working with state-legal cannabis businesses. However, the bill remains stalled in Congress as of mid-2024.

The Crushing Weight of IRS Section 280E

Banking is only half of the financial nightmare for legal cannabis operators. The biggest threat to profitability is a specific federal tax law known as IRS Section 280E.

Enacted in 1982 to target illegal drug traffickers, Section 280E forbids businesses that sell Schedule I or Schedule II controlled substances from deducting standard business expenses on their federal taxes. For a normal retail store, rent, employee payroll, marketing, and health insurance are all tax-deductible. A cannabis dispensary cannot deduct any of these costs.

Dispensaries are only allowed to deduct the Cost of Goods Sold, which is the actual price they paid to acquire the cannabis products.

This creates a devastating economic reality. Because dispensaries cannot write off overhead costs, they pay taxes on their gross margin rather than their net profit. This pushes the effective federal tax rate for a cannabis business to anywhere between 70% and 80%. Small, independent dispensaries often operate at a net loss simply because their federal tax bill erodes every dollar of profit.

State Taxes Add Fuel to the Fire

On top of the severe federal tax penalties, dispensaries must navigate high state and local taxes. State governments view legal cannabis as a massive source of revenue, but aggressive taxation often hurts the legal market.

Consider these specific state tax burdens:

• Washington State: Levies a massive 37% excise tax on retail cannabis sales.
• California: Imposes a 15% state excise tax, but local municipalities often stack their own taxes on top. In some California cities, the combined tax rate approaches 30% to 35% at the register.
• Illinois: Uses a tiered tax system based on THC potency, with taxes reaching up to 25% on products with more than 35% THC.

When state taxes are this high, the cost gets passed down to the consumer. A legal eighth of an ounce of cannabis might cost $60 out the door, while an illegal dealer sells the exact same amount for $25. This vast price difference keeps the illicit market thriving and directly undercuts the heavily regulated legal dispensaries.

The 2024 Turning Point: Schedule III Reclassification

The economics of the legal cannabis market may completely change before the end of 2024. In May 2024, the Department of Justice officially proposed moving marijuana from Schedule I to Schedule III under the Controlled Substances Act.

This single administrative change would radically alter the financial health of the industry. Because IRS Section 280E only applies to Schedule I and Schedule II substances, moving cannabis to Schedule III would immediately eliminate this massive tax burden.

Major publicly traded cannabis companies like Trulieve, Curaleaf, and Green Thumb Industries would save hundreds of millions of dollars annually. Trulieve recently claimed a $113 million tax refund by challenging the application of 280E, signaling that companies are already positioning themselves for a post-280E economy. For independent shops, the ability to deduct payroll and rent could be the difference between closing their doors and finally turning a profit.

Frequently Asked Questions

Why do dispensaries only take cash? Major credit card companies like Visa and Mastercard, along with national banks, operate under federal law. Because cannabis is federally illegal, these companies block transactions to avoid violating federal money laundering statutes.

What is IRS Section 280E? Section 280E is a federal tax code that prevents businesses selling Schedule I or II drugs from deducting regular business expenses on their taxes. This forces cannabis businesses to pay taxes on their gross revenue rather than their net income.

Will the SAFER Banking Act pass in 2024? The SAFER Banking Act has passed the House of Representatives multiple times in previous forms but continues to face delays in the Senate. While industry leaders are pushing for a vote in 2024, its passage remains uncertain.

How will rescheduling cannabis to Schedule III help dispensaries? Moving cannabis to Schedule III removes it from the restrictions of IRS Section 280E. This will allow dispensaries to finally deduct normal operating costs like rent and payroll, drastically lowering their tax bills and improving profit margins.